HCA Healthcare Inc (NYSE:HCA) SVP Sells $307,746.00 in Stock

Share on StockTwits

HCA Healthcare Inc (NYSE:HCA) SVP Deborah M. Reiner sold 2,050 shares of the firm’s stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of $150.12, for a total value of $307,746.00. Following the completion of the transaction, the senior vice president now owns 5,484 shares in the company, valued at $823,258.08. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of NYSE:HCA opened at $149.57 on Friday. The company has a market cap of $51.18 billion, a P/E ratio of 14.37, a PEG ratio of 1.19 and a beta of 0.93. HCA Healthcare Inc has a one year low of $110.31 and a one year high of $151.97. The business’s 50-day simple moving average is $146.75 and its 200 day simple moving average is $134.29.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 28th. The company reported $3.09 EPS for the quarter, meeting the consensus estimate of $3.09. The business had revenue of $13.52 billion for the quarter, compared to the consensus estimate of $13.37 billion. HCA Healthcare had a negative return on equity of 242.04% and a net margin of 6.83%. The company’s revenue was up 10.2% on a year-over-year basis. During the same period last year, the business posted $3.01 EPS. Equities research analysts expect that HCA Healthcare Inc will post 11.68 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 2nd will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date is Friday, February 28th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.40. HCA Healthcare’s dividend payout ratio (DPR) is 15.24%.

HCA has been the topic of several analyst reports. JPMorgan Chase & Co. raised their target price on HCA Healthcare from $157.00 to $186.00 and gave the company an “overweight” rating in a report on Friday, December 20th. Royal Bank of Canada raised their target price on HCA Healthcare from $170.00 to $173.00 and gave the company an “outperform” rating in a report on Wednesday, January 29th. Robert W. Baird raised their target price on HCA Healthcare from $160.00 to $180.00 and gave the company an “outperform” rating in a report on Wednesday, January 29th. Deutsche Bank initiated coverage on HCA Healthcare in a report on Friday, January 3rd. They set a “buy” rating and a $140.00 target price on the stock. Finally, Stephens raised their target price on HCA Healthcare from $175.00 to $180.00 and gave the company an “overweight” rating in a report on Wednesday, January 29th. Two equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $163.81.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. NuWave Investment Management LLC grew its position in shares of HCA Healthcare by 947.4% during the third quarter. NuWave Investment Management LLC now owns 398 shares of the company’s stock worth $47,000 after buying an additional 360 shares in the last quarter. DNB Asset Management AS boosted its holdings in HCA Healthcare by 4.1% in the third quarter. DNB Asset Management AS now owns 53,470 shares of the company’s stock valued at $6,439,000 after purchasing an additional 2,120 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in HCA Healthcare by 14.2% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 17,071 shares of the company’s stock valued at $2,055,000 after purchasing an additional 2,119 shares in the last quarter. Campbell & CO Investment Adviser LLC acquired a new position in HCA Healthcare in the third quarter valued at approximately $594,000. Finally, Advisor Partners LLC boosted its holdings in HCA Healthcare by 8.6% in the third quarter. Advisor Partners LLC now owns 4,949 shares of the company’s stock valued at $596,000 after purchasing an additional 390 shares in the last quarter. Hedge funds and other institutional investors own 69.54% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Asset Allocation, Balancing Your Investments

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.